Vivodyne

Vivodyne is a Philadelphia-based biotech startup founded in 2020, operating at the intersection of AI, drug delivery, and medical devices. The company has developed an integrated platform that uses lab-grown human organs, massive robotic automation, and multimodal AI to generate and analyze human physiological data preclinically. This approach is designed to identify new therapeutic targets, optimize drug candidates, and predict clinical outcomes with greater accuracy than traditional animal models. The company is privately held, has raised significant Series A financing, and partners with biopharma companies to advance therapeutics.

Integrated platform combining lab-grown human organ models, robotic automation for high-throughput testing on 10,000+ tissues simultaneously, and multimodal AI for experimental design and clinical outcome prediction.

Competes with other organ-on-a-chip companies (e.g., Emulate, CN Bio) and contract research organizations (CROs) offering alternative testing models. Differentiation lies in the combination of massive scale through automation, a broad portfolio of organ models, and a closed-loop AI system for experimental design and prediction.